Sectoral Asset Management as of June 30, 2017
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 61 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pfizer (PFE) | 5.2 | $47M | 1.4M | 33.59 | |
| Johnson & Johnson (JNJ) | 5.1 | $47M | 354k | 132.29 | |
| Novartis (NVS) | 5.1 | $47M | 559k | 83.47 | |
| Merck & Co (MRK) | 5.1 | $47M | 730k | 64.09 | |
| Medtronic (MDT) | 3.9 | $35M | 398k | 88.75 | |
| Amicus Therapeutics (FOLD) | 3.8 | $35M | 3.5M | 10.07 | |
| Abiomed | 3.6 | $33M | 229k | 143.30 | |
| Regeneron Pharmaceuticals (REGN) | 3.4 | $31M | 63k | 491.14 | |
| ACADIA Pharmaceuticals (ACAD) | 3.4 | $31M | 1.1M | 27.89 | |
| Celgene Corporation | 3.3 | $30M | 234k | 129.87 | |
| NuVasive | 3.3 | $30M | 393k | 76.92 | |
| Acadia Healthcare (ACHC) | 3.3 | $30M | 603k | 49.38 | |
| BioMarin Pharmaceutical (BMRN) | 3.1 | $29M | 313k | 90.82 | |
| K2m Group Holdings | 2.7 | $25M | 1.0M | 24.36 | |
| Dex (DXCM) | 2.7 | $24M | 333k | 73.15 | |
| Portola Pharmaceuticals | 2.6 | $24M | 422k | 56.17 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.5 | $23M | 1.8M | 12.51 | |
| Aerie Pharmaceuticals | 2.3 | $21M | 403k | 52.55 | |
| Teva Pharmaceutical Industries (TEVA) | 2.2 | $20M | 602k | 33.22 | |
| Mylan Nv | 2.1 | $19M | 496k | 38.82 | |
| Edwards Lifesciences (EW) | 2.1 | $19M | 160k | 118.24 | |
| Teladoc (TDOC) | 2.1 | $19M | 543k | 34.70 | |
| Acceleron Pharma | 2.0 | $18M | 605k | 30.39 | |
| Loxo Oncology | 1.9 | $18M | 222k | 80.19 | |
| La Jolla Pharmaceuticl Com Par | 1.9 | $18M | 590k | 29.77 | |
| Intuitive Surgical (ISRG) | 1.7 | $15M | 17k | 935.39 | |
| Evolent Health (EVH) | 1.5 | $14M | 533k | 25.35 | |
| Integra LifeSciences Holdings (IART) | 1.4 | $13M | 244k | 54.51 | |
| Global Blood Therapeutics In | 1.4 | $12M | 453k | 27.35 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $11M | 239k | 46.00 | |
| Neuroderm Ltd F | 1.1 | $11M | 350k | 29.90 | |
| Wright Medical Group Nv | 1.1 | $10M | 374k | 27.49 | |
| Endo International (ENDPQ) | 1.0 | $9.2M | 821k | 11.17 | |
| NxStage Medical | 1.0 | $8.8M | 350k | 25.07 | |
| Envision Healthcare | 0.9 | $8.3M | 133k | 62.67 | |
| Prothena (PRTA) | 0.9 | $8.2M | 151k | 54.12 | |
| Irhythm Technologies (IRTC) | 0.9 | $7.9M | 185k | 42.49 | |
| Masimo Corporation (MASI) | 0.7 | $6.7M | 73k | 91.17 | |
| Agios Pharmaceuticals (AGIO) | 0.7 | $6.4M | 124k | 51.45 | |
| Dbv Technologies S A (DBVT) | 0.7 | $6.4M | 179k | 35.71 | |
| Spark Therapeutics | 0.7 | $6.1M | 101k | 59.74 | |
| Momenta Pharmaceuticals | 0.6 | $5.1M | 299k | 16.90 | |
| Albireo Pharma | 0.4 | $3.9M | 189k | 20.60 | |
| Ra Pharmaceuticals | 0.4 | $3.3M | 179k | 18.74 | |
| Clovis Oncology | 0.3 | $3.0M | 32k | 93.64 | |
| Illumina (ILMN) | 0.3 | $2.9M | 17k | 173.53 | |
| Accuray Incorporated (ARAY) | 0.3 | $2.8M | 588k | 4.75 | |
| Incyte Corporation (INCY) | 0.3 | $2.8M | 22k | 125.93 | |
| CIGNA Corporation | 0.3 | $2.6M | 16k | 167.38 | |
| Insmed (INSM) | 0.3 | $2.5M | 146k | 17.16 | |
| Versartis | 0.2 | $1.8M | 105k | 17.45 | |
| Obseva Sa | 0.2 | $1.8M | 213k | 8.55 | |
| Immune Design | 0.2 | $1.6M | 168k | 9.75 | |
| Spring Bk Pharmaceuticals In | 0.2 | $1.5M | 113k | 13.54 | |
| Ptc Therapeutics I (PTCT) | 0.1 | $1.1M | 61k | 18.33 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $971k | 29k | 33.72 | |
| Sage Therapeutics (SAGE) | 0.1 | $972k | 12k | 79.68 | |
| Dr. Reddy's Laboratories (RDY) | 0.1 | $803k | 19k | 42.12 | |
| Tg Therapeutics (TGTX) | 0.1 | $817k | 81k | 10.05 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $806k | 183k | 4.40 | |
| Sierra Oncology | 0.0 | $236k | 202k | 1.17 |
